Oscar Health (NYSE:OSCR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) by 13.26 percent. This is a 140.91 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $2.986 billion which missed the analyst consensus estimate of $3.082 billion by 3.12 percent. This is a 23.24 percent increase over sales of $2.423 billion the same period last year.